Inclusion and Exclusion Criteria
The criteria for inclusion in the study were as follows: patients with elevated prostate specific antigen (PSA) level and/or anormal findings in digital rectal examination. Patients with diagnosed a diesease of urinary tract infections, coagulopathies, patients who have had surgery in the past year or patients who received only 5-alfa reductase inhibitory treatment or as a combination therapy and patients with inadequate data were also excluded from the study.